biosciences/Lancet
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.Kimathi, D.
Juan-Giner, A.
Bob, N. S.
Orindi, B.
Namulwana, M. L.
Diatta, A.
Cheruiyot, S.
Fall, G.
Dia, M.
Hamaluba, M. M.
Nyehangane, D.
Karanja, H. K.
Gitonga, J. N.
Mugo, D.
Omuoyo, D. O.
Hussein, M.
Oloo, E.
Kamau, N.
Wafula, J.
Bendera, J.
Silvester, N.
Mwavita, J.
Joshua, M.
Thuranira, J. M.
Agababyona, C.
Ngetsa, C.
Aisha, N.
Moki, F.
Buluku, T.
Munene, M.
Mwanga-Amumpaire, J.
Lutwama, J.
Kayiwa, J.
Kamaara, E.
Barrett, A. D.
Kaleebu, P.
Bejon, P.
Sall, A. A.
Grais, R. F.
Warimwe, G. M.
Lancet, (2026). 407:497-504
Regional action needed to halt antimalarial drug resistance in Africa.Martinez-Vega, R.
Ishengoma, D. S.
Gosling, R.
Rosenthal, P. J.
Dondorp, A.
Barnes, K. I.
Nsanzabana, C.
Djimde, A. A.
Ochola-Oyier, L. I.
Tibenderana, J.
Chimumbwa, J.
Golassa, L.
Kapologwe, N. A.
Mbacham, W. F.
Kamya, M. R.
Fidock, D. A.
Komatsu, R.
von Seidlein, L.
Dhorda, M.
Lancet, (2025). 405:7-10
Feasibility, safety, and impact of the RTS,S/AS01(E) malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and Malawi.Asante, K. P.
Mathanga, D. P.
Milligan, P.
Akech, S.
Oduro, A.
Mwapasa, V.
Moore, K. A.
Kwambai, T. K.
Hamel, M. J.
Gyan, T.
Westercamp, N.
Kapito-Tembo, A.
Njuguna, P.
Ansong, D.
Kariuki, S.
Mvalo, T.
Snell, P.
Schellenberg, D.
Welega, P.
Otieno, L.
Chimala, A.
Afari, E. A.
Bejon, P.
Maleta, K.
Agbenyega, T.
Snow, R. W.
Zulu, M.
Chinkhumba, J.
Samuels, A. M.
Malaria Vaccine Programme Evaluation, Partners
Lancet, (2024). 403:1660-1670
Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial.Datoo, M. S.
Dicko, A.
Tinto, H.
Ouedraogo, J. B.
Hamaluba, M.
Olotu, A.
Beaumont, E.
Ramos Lopez, F.
Natama, H. M.
Weston, S.
Chemba, M.
Compaore, Y. D.
Issiaka, D.
Salou, D.
Some, A. M.
Omenda, S.
Lawrie, A.
Bejon, P.
Rao, H.
Chandramohan, D.
Roberts, R.
Bharati, S.
Stockdale, L.
Gairola, S.
Greenwood, B. M.
Ewer, K. J.
Bradley, J.
Kulkarni, P. S.
Shaligram, U.
Hill, A. V. S.
R. 1/Matrix-M Phase 3 Trial Group
Lancet, (2024). 403:533-544
Immunogenicity and safety of fractional doses of yellow fever vaccines: a randomised, double-blind, non-inferiority trial.Juan-Giner, A.
Kimathi, D.
Grantz, K. H.
Hamaluba, M.
Kazooba, P.
Njuguna, P.
Fall, G.
Dia, M.
Bob, N. S.
Monath, T. P.
Barrett, A. D.
Hombach, J.
Mulogo, E. M.
Ampeire, I.
Karanja, H. K.
Nyehangane, D.
Mwanga-Amumpaire, J.
Cummings, D. A. T.
Bejon, P.
Warimwe, G. M.
Grais, R. F.
Lancet, (2021). 397:119-127
Effect of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease and nasopharyngeal carriage in Kenya: a longitudinal surveillance study.Hammitt, L. L.
Etyang, A. O.
Morpeth, S. C.
Ojal, J.
Mutuku, A.
Mturi, N.
Moisi, J. C.
Adetifa, I. M.
Karani, A.
Akech, D. O.
Otiende, M.
Bwanaali, T.
Wafula, J.
Mataza, C.
Mumbo, E.
Tabu, C.
Knoll, M. D.
Bauni, E.
Marsh, K.
Williams, T. N.
Kamau, T.
Sharif, S. K.
Levine, O. S.
Scott, J. A. G.
Lancet, (2019). 393:2146-2154
Relation between falciparum malaria and bacteraemia in Kenyan children: a population-based, case-control study and a longitudinal study.Scott, J. A.
Berkley, J. A.
Mwangi, I.
Ochola, L.
Uyoga, S.
Macharia, A.
Ndila, C.
Lowe, B. S.
Mwarumba, S.
Bauni, E.
Marsh, K.
Williams, T. N.
Lancet, (2011). 378:1316-23
Research priorities for malaria elimination.Marsh, K.
Lancet, (2010). 376:1626-7
Malaria in Africa: progress and prospects in the decade since the Abuja Declaration.Snow, R. W.
Marsh, K.
Lancet, (2010). 376:137-9
Bacteraemia in Kenyan children with sickle-cell anaemia: a retrospective cohort and case-control study.Williams, T. N.
Uyoga, S.
Macharia, A.
Ndila, C.
McAuley, C. F.
Opi, D. H.
Mwarumba, S.
Makani, J.
Komba, A.
Ndiritu, M. N.
Sharif, S. K.
Marsh, K.
Berkley, J. A.
Scott, J. A.
Lancet, (2009). 374:1364-70
Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya.O'Meara, W. P.
Bejon, P.
Mwangi, T. W.
Okiro, E. A.
Peshu, N.
Snow, R. W.
Newton, C. R.
Marsh, K.
Lancet, (2008). 372:1555-62
WHO, the Global Fund, and medical malpractice in malaria treatment.White, N.
Nosten, F.
Bjorkman, A.
Marsh, K.
Snow, R. W.
Lancet, (2004). 363:1160
Variant surface antigen-specific IgG and protection against clinical consequences of pregnancy-associated Plasmodium falciparum malaria.Staalsoe, T.
Shulman, C. E.
Bulmer, J. N.
Kawuondo, K.
Marsh, K.
Hviid, L.
Lancet, (2004). 363:283-9
Chlorproguanil-dapsone versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi: a randomised clinical trial.Sulo, J.
Chimpeni, P.
Hatcher, J.
Kublin, J. G.
Plowe, C. V.
Molyneux, M. E.
Marsh, K.
Taylor, T. E.
Watkins, W. M.
Winstanley, P. A.
Lancet, (2002). 360:1136-43
Chlorproguanil-dapsone for treatment of drug-resistant falciparum malaria in Tanzania.Mutabingwa, T.
Nzila, A.
Mberu, E.
Nduati, E.
Winstanley, P.
Hills, E.
Watkins, W.
Lancet, (2001). 358:1218-23
Diagnosis of acute bacterial meningitis in children at a district hospital in sub-Saharan Africa.Berkley, J. A.
Mwangi, I.
Ngetsa, C. J.
Mwarumba, S.
Lowe, B. S.
Marsh, K.
Newton, C. R.
Lancet, (2001). 357:1753-7
A non-sense mutation in Cd36 gene is associated with protection from severe malaria.Pain, A.
Urban, B. C.
Kai, O.
Casals-Pascual, C.
Shafi, J.
Marsh, K.
Roberts, D. J.
Lancet, (2001). 357:1502-3
Autoagglutination of malaria-infected red blood cells and malaria severity.Roberts, D. J.
Pain, A.
Kai, O.
Kortok, M.
Marsh, K.
Lancet, (2000). 355:1427-8
Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya.Scott, J. A.
Hall, A. J.
Muyodi, C.
Lowe, B.
Ross, M.
Chohan, B.
Mandaliya, K.
Getambu, E.
Gleeson, F.
Drobniewski, F.
Marsh, K.
Lancet, (2000). 355:1225-30
Effect of phenobarbital on seizure frequency and mortality in childhood cerebral malaria: a randomised, controlled intervention study.Crawley, J.
Waruiru, C.
Mithwani, S.
Mwangi, I.
Watkins, W.
Ouma, D.
Winstanley, P.
Peto, T.
Marsh, K.
Lancet, (2000). 355:701-6